Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic liver disease |
| |
| Affiliation: | 1. Department of Human and Systems Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea;2. Center for Neuroscience, Korea Institute of Science and Technology, Seoul, Republic of Korea;3. Department of Neuroscience, University of Science and Technology, Daejeon, Republic of Korea;4. Department of Human and Systems Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea |
| |
| Abstract: | To evaluate the therapeutic efficacy of Stronger Neo-Minophagen C (SNMC) in patients with chronic liver diseases, a multicenter prospective study was performed in Beijing, China. A total of 109 patients were treated with SNMC intravenous injection and SNMC tablets (Minophagen Pharmaceutical Co., Tokyo, Japan). They responded to the treatment with marked effective rate of 66% and overall effective rate of 75%. SNMC was shown to lower serum ALT and AST levels shortly after the administration, especially for the patients with higher serum levels. Serum bilirubin was reduced simultaneously, and metabolism of protein was improved. SNMC was proved to be safe with minimal side effects. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
